1. Catalpol inhibits TGF‐β1‐induced epithelial‐mesenchymal transition in human non–small‐cell lung cancer cells through the inactivation of Smad2/3 and NF‐κB signaling pathways
   Zuopei Wang et al, 2019, Journal of Cellular Biochemistry CrossRef
2. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma
   Lina Zhao et al, 2019, Experimental and Molecular Pathology CrossRef
3. Multiple Biological Effects of an Iridoid Glucoside, Catalpol, and Its Underlying Molecular Mechanisms
   Subrat Kumar Bhattamisra et al, 2019, Biomolecules CrossRef
4. Synthesis, characterization, structural-activity relationship and biomolecular interaction studies of heteroleptic Pd(II) complexes with acetyl pyridine scaffold
   Nikita J. Patel et al, 2020, Journal of Molecular Structure CrossRef
5. The effects of Pinoresinol diglucoside on the differentiation and bone resorption of osteoclast RAW264.7
   Zhefeng JIN et al, 2022, Food Science and Technology CrossRef
6. Catalpol suppresses osteoclastogenesis and attenuates osteoclast-derived bone resorption by modulating PTEN activity
   Jiahong Meng et al, 2020, Biochemical Pharmacology CrossRef
7. Anti-inflammatory and Anti-endoplasmic reticulum stress Effects of catalpol Against myocardial ischemia-reperfusion injury in streptozotocin-induced diabetic rats
   FANGJIE BI et al, 2020, Anais da Academia Brasileira de Ciências CrossRef
8. Potential Roles of Iridoid Glycosides and Their Underlying Mechanisms against Diverse Cancer Growth and Metastasis: Do They Have an Inhibitory Effect on Cancer Progression?
   Cho-Won Kim et al, 2021, Nutrients CrossRef
9. Phytochemicals and Nanoparticles in the Modulation of PI3K/Akt/mTOR Kinases and its Implications in the Development and Progression of Gastrointestinal Cancers: A Review of Preclinical and Clinical Evidence
   Arunaksharan Narayanankutty et al, 2023, Recent Patents on Anti-Cancer Drug Discovery CrossRef
10. Establishment and elicitation of transgenic root culture of Plantago lanceolata and evaluation of its anti-bacterial and cytotoxicity activity
    Samaneh Rahamouz-Haghighi et al, 2021, Preparative Biochemistry & Biotechnology CrossRef
11. Phytochemical Regulation of RNA in Treating Inflammatory Bowel Disease and Colon Cancer: Inspirations from Cell and Animal Studies
    Guolin Zhang et al, 2021, Journal of Pharmacology and Experimental Therapeutics CrossRef
12. Downregulation of Lgr6 inhibits proliferation and invasion and increases apoptosis in human colorectal cancer
    Fei Wang et al, 2018, International Journal of Molecular Medicine CrossRef
13. The Impact of Catalpol on Proliferation, Apoptosis, Migration, and Oxidative Stress of Lung Cancer Cells Based on Nrf2/ARE Signaling
    Huanyuan Wang et al, 2022, BioMed Research International CrossRef
14. Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways
    Sara Muhammad El-Hanboshy et al, 2021, Molecular Biology Reports CrossRef
15. Catalpol exerts antiallergic effects in IgE/ovalbumin-activated mast cells and a murine model of ovalbumin-induced allergic asthma
    Ming-Huang Chiu et al, 2021, International Immunopharmacology CrossRef
16. PI3K/ Akt/ mTOR Pathway as a Therapeutic Target for Colorectal Cancer: A Review of Preclinical and Clinical Evidence
    Arunaksharan Narayanankutty, 2019, Current Drug Targets CrossRef
17. The Jieduan-Niwan (JDNW) Formula Ameliorates Hepatocyte Apoptosis: A Study of the Inhibition of E2F1-Mediated Apoptosis Signaling Pathways in Acute-on-Chronic Liver Failure (ACLF) Using Rats
    Weixin Hou et al, 2021, Drug Design, Development and Therapy CrossRef
18. Protection of catalpol against triptolide-induced hepatotoxicity by inhibiting excessive autophagy via the PERK-ATF4-CHOP pathway
    Linluo Zhang et al, 2022, PeerJ CrossRef
19. Design, Synthesis and Biological Evaluation of Novel Catalpol Derivatives as Potential Pancreatic Cancer Inhibitors
    Yuanfang Kong et al, 2023, Chemistry – An Asian Journal CrossRef
20. MicroRNA-126 regulates the phosphatidylinositol-3 kinase (PI3K)/protein kinase B (AKT) pathway in SLK cells in vitro and the expression of its pathway members in Kaposi's sarcoma tissue
    Gaihui Lu et al, 2018, Medicine CrossRef
21. Iridoid Derivatives as Anticancer Agents: An Updated Review from 1970–2022
    Tanaka Ndongwe et al, 2023, Cancers CrossRef
22. Catalpol rescues cognitive deficits by attenuating amyloid β plaques and neuroinflammation
    Si Li et al, 2023, Biomedicine & Pharmacotherapy CrossRef
23. Catalpol Weakens Depressive-like Behavior in Mice with Streptozotocin-induced Hyperglycemia via PI3K/AKT/Nrf2/HO-1 Signaling Pathway
    Xiaohui Wu et al, 2021, Neuroscience CrossRef
24. Advances in Structural Modification and Pharmacological Activity of Catalpol and its Derivatives
    Shuanglin Liu et al, 2021, ChemistrySelect CrossRef